HBIO Stock Analysis: Buy, Sell, or Hold?
HBIO - Harvard Bioscience Inc
$5.59
0.07 (1.27%)
▲
5d:
+6.48%
30d:
-17.55%
90d:
+885.2%
BUY
HIGH Confidence
Analysis Updated: May 22, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Get Alerted When HBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: HBIO shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: HBIO shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.50
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$2.79
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HBIO is currently trading at $5.59, which is considered slightly low relative to its 30-day fair value range of $5.53 to $6.85. From a valuation perspective, the stock is trading at a premium (Forward PE: 12.7) compared to its historical average (7.3). At these levels, the market is pricing in 20.2% annual earnings growth.
Technical Outlook: Technically, HBIO is in a strong uptrend. Immediate support is located at $4.87, while resistance sits at $7.15.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HBIO is in a strong uptrend. Immediate support is located at $4.87, while resistance sits at $7.15.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$5.53 -
$6.85
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($6.00)
- BULLISH: Expecting earnings turnaround to 20.2% growth with -4.7% revenue growth
Trading Range Analysis
30-Day Trading Range
$5.53 -
$6.85
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$4.87
Resistance Level
$7.15
Current Trend
Strong Uptrend
Technical data as of
May 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.70
Wall Street Target
$6.00
(+7.3%)
Revenue Growth (YoY)
-4.7%
Earnings Growth (YoY)
-80.3%
Profit Margin
-11.4%
Valuation Premium vs History
+20.2% premium
PE vs Historical
12.7 vs 7.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+20.2%
(market-implied from PE analysis)
1-Year Target
$6.72
(+20%)
2-Year Target
$8.08
(+45%)
3-Year Target
$9.71
(+74%)
3-Yr Target (if PE normalizes)
(PE: 13→7)
PE COMPRESSION
$5.58
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: May 25, 2026 7:11 AM ET
Data refreshes hourly during market hours. Next update: 8:11 AM
Data refreshes hourly during market hours. Next update: 8:11 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HBIO showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Stephen J Denelsky
BUY
10000 shares
2026-03-17
William Snider
BUY
8475 shares
2026-03-17
John D Duke
BUY
5000 shares
2026-03-16
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$573 | 59 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 52 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$271 | 59 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$179 | 47 HOLD |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$91 | 61 BUY |
